Biotech stocks aren’t generally known for their dividends. There are a few exceptions, but as a rule most biotechs either don’t have the ability to reward shareholders with dividends, or they need the cash to fuel additional growth. However, some biotechs could easily pay dividends if they wanted to, even though they don’t do so right now. Put Celgene, Biogen and Regeneron at the top of the list.
